Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.

Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P, Trimoulet P, Dabis F, Salmon-Ceron D, Izopet J; ANRS CO13 HEPAVIH Study Group.

PLoS One. 2012;7(11):e50289. doi: 10.1371/journal.pone.0050289. Epub 2012 Nov 30.

2.

Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients?

Saracino A, Bruno G, Scudeller L, Punzi G, Lagioia A, Ladisa N, Monno L, Angarano G.

J Clin Virol. 2014 Mar;59(3):167-71. doi: 10.1016/j.jcv.2013.12.009. Epub 2014 Jan 3.

PMID:
24461764
3.

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.

Macías J, Berenguer J, Japón MA, Girón JA, Rivero A, López-Cortés LF, Moreno A, González-Serrano M, Iribarren JA, Ortega E, Miralles P, Mira JA, Pineda JA.

Hepatology. 2009 Oct;50(4):1056-63. doi: 10.1002/hep.23136.

PMID:
19670415
4.
5.

Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients.

Mariné-Barjoan E, Saint-Paul MC, Pradier C, Chaillou S, Anty R, Michiels JF, Sattonnet C, Ouzan D, Dellamonica P, Tran A; Registre des Ponctions-Biopsies Hépatiques.

AIDS. 2004 Nov 5;18(16):2163-70.

PMID:
15577649
6.

Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients.

Tural C, Fuster D, Tor J, Ojanguren I, Sirera G, Ballesteros A, Lasanta JA, Planas R, Rey-Joly C, Clotet B.

J Viral Hepat. 2003 Mar;10(2):118-25.

PMID:
12614468
7.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.

Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.

J Viral Hepat. 2009 Nov;16(11):790-5. doi: 10.1111/j.1365-2893.2009.01133.x. Epub 2009 Apr 28.

PMID:
19413693
8.

Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.

Sanmartin R, de Felipe E, Tor J, Sanvicens A, Barluenga E, Martinez E, Muga R, Jou A, Ojanguren I, López JJ, Clotet B, Tural C.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1235-43. Epub 2012 Apr 20.

PMID:
22443303
9.

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.

Aranzabal L, Casado JL, Moya J, Quereda C, Diz S, Moreno A, Moreno L, Antela A, Perez-Elias MJ, Dronda F, Marín A, Hernandez-Ranz F, Moreno A, Moreno S.

Clin Infect Dis. 2005 Feb 15;40(4):588-93. Epub 2005 Jan 21.

10.

Co-receptor switch during HAART is independent of virological success.

Saracino A, Monno L, Cibelli DC, Punzi G, Brindicci G, Ladisa N, Tartaglia A, Lagioia A, Angarano G.

J Med Virol. 2009 Dec;81(12):2036-44. doi: 10.1002/jmv.21598.

PMID:
19856465
11.

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.

Mohsen AH, Easterbrook PJ, Taylor C, Portmann B, Kulasegaram R, Murad S, Wiselka M, Norris S.

Gut. 2003 Jul;52(7):1035-40.

12.

Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients?

Verma S, Wang CH, Govindarajan S, Kanel G, Squires K, Bonacini M.

Clin Infect Dis. 2006 Jan 15;42(2):262-70. Epub 2005 Dec 2.

13.

Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.

Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.

AIDS. 2008 Jul 31;22(12):1425-31. doi: 10.1097/QAD.0b013e32830184ba.

PMID:
18614865
14.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9. Epub 2006 Feb 21.

15.

Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.

Li Vecchi V, Soresi M, Colomba C, Mazzola G, Colletti P, Mineo M, Di Carlo P, La Spada E, Vizzini G, Montalto G.

World J Gastroenterol. 2010 Nov 7;16(41):5225-32.

16.

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.

Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M.

J Viral Hepat. 2010 Jun;17(6):400-9. doi: 10.1111/j.1365-2893.2009.01197.x. Epub 2009 Sep 15.

PMID:
19780945
17.

The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.

Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.

Clin Infect Dis. 2008 May 15;46(10):1617-23. doi: 10.1086/587660.

18.

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.

Benhamou Y, Di Martino V, Bochet M, Colombet G, Thibault V, Liou A, Katlama C, Poynard T; MultivirC Group.

Hepatology. 2001 Aug;34(2):283-7.

PMID:
11481613
19.

Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection.

Li Vecchi V, Soresi M, Giannitrapani L, Di Carlo P, Mazzola G, Colletti P, Terranova A, Vizzini G, Montalto G.

Int J Infect Dis. 2012 May;16(5):e397-402. doi: 10.1016/j.ijid.2012.01.011. Epub 2012 Mar 17.

20.

Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.

Sanmartín R, Tor J, Sanvisens A, López JJ, Jou A, Muga R, Ojanguren I, Barluenga E, Videla S, Planas R, Clotet B, Tural C.

HIV Med. 2014 Apr;15(4):203-12. doi: 10.1111/hiv.12105. Epub 2013 Nov 19.

PMID:
24245909
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk